From: Survival prognostic and recurrence risk factors after single pulmonary metastasectomy
Single PM | 162 |
---|---|
Sex | |
Female | 72 (44.4%) |
Male | 90 (55.6%) |
Age (median) | 64 [IQR 55–71] |
Comorbidities | |
Cardiopathy | 12 (7.4%) |
High blood pressure | 61 (37.7%) |
Pulmonary disease | 13 (8%) |
Tobacco exposure | 49 (30.3%) |
Diabetes | 23 (14.2%) |
Renal failure | 11 (6.8%) |
Immunosuppression | 6 (3.7%) |
Primary tumour | |
Colorectal | 51 (31.5%) |
Melanoma | 33 (20.4%) |
Sarcoma | 24 (14.8%) |
Other | 54 (33.3%) |
Pulmonary metastasis | |
Size [mm] (median) | 10.5 [7–16] |
Margins [mm] (median) | 6 [3–12] |
R0 | 159 (98.2%) |
R1 | 3 (1.9%) |
Lymph node involvement | 9 (5.6%) |
First PM | |
VATS | 136 (83.9%) |
Thoracotomy | 26 (16.1%) |
Wedge resection | 119 (73.5%) |
Segmentectomy | 12 (7.4%) |
Lobectomy | 29 (17.9%) |
Pneumonectomy | 2 (1.2%) |
Mediastinal lymph nodes dissection | 36 (22.2%) |
Post-operative outcomes | |
Overall 30-d mortality | 0 |
Overall 30-d morbidity | 19 (11.7%) |
Pulmonary complications | 12 (7.4%) |
Cardiac complications | 3 (1.9%) |
Duration of drainage [days] (median) | 1 [IQR 1–2] |
Duration of hospital stay [days] (median) | 4 [IQR 3–7] |
Readmission (30-d) | 2 (1.2%) |
Re-operation (30-d) | 1 (0.6%) |